HomeProductsBuilding BlocksHeterocyclic ScaffoldsQuinolinesSitamaquine
Chemical structure of CAS 57695-04-2

Sitamaquine

CAS No.57695-04-2
MDL No.N/A
MFC21H33N3O
MW343.50
InChI KeyRVAKDGYPIVSYEU-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.57695-04-2
Product NameSitamaquine

Associated Conditions

Leishmaniasis
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Transition metal complexes of quinolino[3,2-b]benzodiazepine and quinolino[3,2-b]benzoxazepine: synthesis, characterization, and antimicrobial studies.

Bioinorganic chemistry and applications • Vol. 2007 • 2007
PMID: 18273383PMC: PMC2216056DOI: 10.1155/2007/42587

Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.

The Journal of the Association of Physicians of India • Vol. 51 • 2003
PMID: 14621038

Sitamaquine (GlaxoSmithKline/Walter Reed Army Institute).

Current opinion in investigational drugs (London, England : 2000) • Vol. 3, Issue 10 • 2002
PMID: 12431016

New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii.

Journal of medicinal chemistry • Vol. 38, Issue 24 • 1995
PMID: 7490723DOI: 10.1021/jm00024a001

Documentation

Similar Products